Liberta RC™ deep brain stimulation (DBS) system, recently approved by the U.S. FDA, features NeuroSphere™ Virtual Clinic, which allows for remote programming of the system System offers the longest ...
Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...
Credit: Abbott. Liberta RC DBS is the smallest rechargeable DBS device featuring the NeuroSphere Virtual Clinical, which allows for remote programming capabilities. The Food and Drug Administration ...
For Abbott, good things come in tiny packages. The devicemaker’s Liberta RC implant—the smallest rechargeable, remote programming-equipped deep brain stimulation system not just in Abbott’s portfolio, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results